Association of caffeine consumption with cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease: A BALTAZAR cohort study.

MLA

Blum, David, et al. “Association of Caffeine Consumption with Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment and Alzheimer’s Disease: A BALTAZAR Cohort Study.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, vol. 20, no. 10, Oct. 2024, pp. 6948–59. EBSCOhost, https://doi.org/10.1002/alz.14169.

APA

Blum, D., Cailliau, E., Béhal, H., Vidal, J., Delaby, C., Buée, L., Allinquant, B., Gabelle, A., Bombois, S., Lehmann, S., Schraen, M. S., Hanon, O., Blanc, F., Boudali, Y., Touchon, J., Seux, M., Lenoir, H., Bayle, C., Delmaire, C., & Delbeuck, X. (2024). Association of caffeine consumption with cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer’s disease: A BALTAZAR cohort study. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 20(10), 6948–6959. https://doi.org/10.1002/alz.14169

Chicago

Blum, David, Emeline Cailliau, Hélène Béhal, Jean‐Sébastien Vidal, Constance Delaby, Luc Buée, Bernadette Allinquant, et al. 2024. “Association of Caffeine Consumption with Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment and Alzheimer’s Disease: A BALTAZAR Cohort Study.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 20 (10): 6948–59. doi:10.1002/alz.14169.